Friday, May 29, 2015
Updated 4/30/2015
Youth Friendly Pharmacies
Faculty: Donald Downing, R.Ph., Clinical Professor, University of Washington School of Pharmacy
ACPE # 0130-0000-15-023-L04-P&T | Activity Type: Application | Disclosure: None
Friday, May 29, 8:00am - 9:30am | 1.5 hr | Room: Casco
Target Audience: Community Ambulatory, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Identify three ways to successfully engage other health care providers and youth advocates in the delivery of
youth friendly services
 Describe five essential characteristics of a youth-friendly pharmacy
 Assess pharmacy and youth needs in order to ascertain the youth friendliness of local pharmacies
 Discuss collaborative practice agreements & their value in reducing disparities in teen pregnancy and birth rates
Infectious Disease 2015 Update
Faculty: Colleen Terriff, Pharm.D., MPH, AAHIVP, Clinical Associate Professor, Washington State University
College of Pharmacy and James Lewis II, PharmD, FIDSA, Infectious Diseases Clinical Pharmacy Coordinator,
Oregon Health and Science University
ACPE # 0130-0000-15-024-L01-P&T | Activity Type: Application | Disclosure: Colleen Terriff: consultingspeaking for Getaway Seminars, SRHD-Pharmacy Workgroup, James Lewis: honorarium-consultant from
Accelerate Diagnostics, Astellas, Cubist, Merck, Theravance
Friday, May 29, 8:00am - 9:30am | 1.5 hr | Room: Kidd/North Cape
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist will be able to:
 Recommend appropriate adult vaccinations when given a patient case
 State one advantage and one disadvantage for each new antibiotic
 Discuss at least 2 pros and 2 cons for the direct-acting hepatitis C antiviral agents
At the completion of this program, the Technician will be able to:
 State one advantage and one disadvantage for each new antibiotic
 Discuss at least 2 pros and 2 cons for the direct-acting hepatitis C antiviral agents
This activity will discuss new gram positive antibiotics, immunizations, Hepatitis C treatment breakthroughs and
new gram negative antibiotics.
Recognizing and Responding to Suicide Risk
Faculty: Susan Eastgard, MSW, Director of Training, Forefront- School of Social Work
ACPE # 0130-0000-15-025-L05-P&T | Activity Type: Application | Disclosure: None
Friday, May 29, 8:00am - 9:30am | 1.5 hr | Room: Bay 1
Target Audience: Community Ambulatory, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Explain the magnitude of the problem of suicide in Northwest
 Identify the warning signs and risk factors associated with a client at risk of suicide
 Ask the client directly about suicide
 Identify the intervention and referral options
Pharmacists are in a unique role to save the life of a suicidal client. This activity will illuminate the common risk
factors and warning signs and provide the practitioner with the skills to intervene appropriately. Referral resources
will be identified.
Veterinary Medications in Pharmacy Practice
Faculty: Roland Lopez, Pharm.D., FACA, Pharmacist, Kelley-Ross Compounding Pharmacy
ACPE # 0130-0000-15-026-L01-P&T | Activity Type: Knowledge | Disclosure: None
Friday, May 29, 9:40am - 11:10am | 1.5 hr | Room: Casco
Target Audience: Community Ambulatory, Independent, Technician, Students
At the completion of this program, Pharmacist will be able to:
 Retrieve, interpret and evaluate data from reliable veterinary references
 Describe major differences between human and animal metabolism and toxicities
 Describe commonly dispensed veterinary medications
 Describe the importance of communicating effectively and confidently with veterinarians, veterinary
technicians and other animal health industry professionals
At the completion of this program, Technicians will be able to:
 Describe major differences between human and animal metabolism and toxicities
 Describe commonly dispensed veterinary medications
 Describe the importance of communicating effectively and confidently with veterinarians, veterinary
technicians and other animal health industry professionals
This CE will provide an overview and general considerations of veterinary medication dispensing for small animal
patients in the community pharmacy practice setting.
Infectious Disease Pearls-Hot Topics
Faculty: Colleen Terriff, Pharm.D., MPH, AAHIVP, Clinical Associate Professor, Washington State University
College of Pharmacy and James Lewis II, PharmD, FIDSA, Infectious Diseases Clinical Pharmacy Coordinator,
Oregon Health and Science University
ACPE # 0130-0000-15-027-L01-P&T | Activity Type: Application | Disclosure: Colleen Terriff: consultingspeaking for Getaway Seminars, SRHD-Pharmacy Workgroup, James Lewis: honorarium-consultant from
Accelerate Diagnostics, Astellas, Cubist, Merck, Theravance
Friday, May 29, 9:40am - 11:10am | 1.5 hr | Room: Kidd/North Cape
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist will be able to:
 Recommend a treatment plan when given patient cases with Candida in sputum, an uncomplicated SSTI and C.
difficile
 Debate advantages and disadvantages of cobicistat compared to ritonavir for a PK booster
 Share lessons learned with recent measles outbreak
 Recall what results of D-Zone and Hodge test tell us clinically
 State a unique characteristic learned about isavuconazole
At the completion of this program, the Technican will be able to:
 Explain advantages and disadvantages of cobicistat compared to ritonavir for a PK booster
 Share lessons learned with recent measles outbreak
 Recall what results of D-Zone and Hodge test tell us clinically
 State a unique characteristic learned about isavuconazole
This activity will discuss: What is D-Zone and Hodge test? Does Candida cause pneumonia? Clindamycin vs.
SMX/TMP for uncomplicated skin and soft tissue infection; Cobicistat versus ritonavir in HIV; Measles outbreak:
lessons learned; Clostridium Difficile - there's more to it than your hands; and antifungal update - meet
isavuconazole.
MTM: Tips and Tools for Complete Medication Review Completion in Chronic Disease Management
Faculty: Katherine McCartney Hale, Pharm.D., BCPS, Associate Professor, University of Montana Skaggs School
of Pharmacy
ACPE # 0130-0000-15-028-L01-P&T | Activity Type: Application | Disclosure: None
Friday, May 29, 9:40am - 11:10am | 1.5 hr | Room: Bay 1
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Discuss methods for completing comprehensive medication reviews (CMRs) in chronic disease state
management
 Assess pharmacotherapy and formulate an action plan within the CMR using a case-based approach
 Apply current clinical guidelines to pharmacotherapy management within the CMR
 Address behavior change and lifestyle modification within the CMR
Comprehensive medication reviews in MTM can be overwhelming. What problem should be addressed first? What
issues should I address and when? Is this really an issue? This presentation is designed to discuss various methods
for completing a comprehensive medication review. Using a case-based approach, participants will review
pharmacotherapy, prioritize and address drug-related problems, while incorporating lifestyle change and counseling
techniques.
The Scientific Report of the 2015 Dietary Guidelines Advisory Committee: What’s New, What’s the Same,
and What You Should Eat
Faculty: Skye McKennon, Pharm.D., BCPS, Clinical Assistant Professor University of Utah College of Pharmacy,
Department of Pharmacotherapy
ACPE # 0130-0000-15-029-L04-P&T | Activity Type: Knowledge | Disclosure: None
Friday, May 29, 12:20pm - 1:50pm | 1.5 hr | Room: Casco
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Describe the impetus behind the Scientific Report of the 2015 Dietary Guidelines Advisory Committee
 Compare and contrast the Scientific Report of the 2015 Dietary Guidelines Advisory Committee with previous
dietary recommendations
 State the five focus areas of the Scientific Report of the 2015 Dietary Guidelines Advisory Committee
 Discuss nutrients that are under- and over-consumed according to the Scientific Report of the 2015 Dietary
Guidelines Advisory Committee
 Articulate keys to a healthy dietary pattern as stated in the Scientific Report of the 2015 Dietary Guidelines
Advisory Committee
 Recommend behavior change and environmental support for patients
The Scientific Report of the 2015 Dietary Guidelines Advisory Committee was released in February of 2015 and
will be finalized in May. The guideline was authored by the United States Department of Health and Human
Services and the Department of Agriculture. The guideline presents similar and dramatically different
recommendations for dietary excellence compared to previous guidelines. This CE presentation will compare and
contrast the 2015 guideline with previous recommendations. It will also present a variety of expert opinions on the
new guidelines.
Novel Oral Antithrombotics & Their Emergent Reversal Strategies
Faculty: Christian Hamm, Pharm.D., BCPS, Emergency Medicine Pharmacy Specialist, MultiCare Health System;
and Allison Massingill, Pharm.D., Pharmacist, MultiCare Health System
ACPE # 0130-0000-15-030-L01-P&T | Activity Type: Knowledge | Disclosure: None
Friday, May 29, 12:20pm - 1:50pm | 1.5 hr | Room: Kidd/North Cape
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist will be able to:
• List oral anticoagulants available on the market
• List oral antiplatelets available on the market
• Describe the incidence, morbidity, and mortality associated with oral anticoagulant/antiplatelet-related bleeding
• Identify contemporary reversal strategies to inhibit further bleeding
• Explain the associated costs and risks with current reversal agents
At the completion of this program, the Technician will be able to:
• List oral anticoagulants available on the market
• List oral antiplatelets available on the market
• Describe oral anticoagulant/antiplatelet-related bleeding
• Identify issues with reversing these agents
• Explain the associated costs and risks with current reversal agents
The number of oral anticoagulant and anti-platelet agents continues to increase. Reversal strategies are needed to
treat emergent life threatening bleeding associated with these drugs. Please join us to learn briefly about these new
agents and also current reversal strategies employed in the ER setting.
Preventing Opioid Overdose Deaths
Faculty: Steve Singer, R.Ph., Pharmacist, Bellegrove Pharmacy Services
ACPE # 0130-0000-15-031-L05-P&T | Activity Type: Knowledge | Disclosure: None
Friday, May 29, 12:20pm - 1:50pm | 1.5 hr | Room: Bay 1
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Review the key signs and steps of opioid overdose
 Discuss the steps for opioid overdose reversal
 Review patient education for opioid overdose reversal kits
 Implement strategies to enhance patient safety with opioids dispensed in the pharmacy
Independent Pharmacy Forum: Being Your Best Online, and Legislative Update for Independents
Moderator: Kirk Heinz, R.Ph., Owner, Kirk’s Pharmacy
Faculty: Carl Britton Jr., President, In Their Face Marketing, Matthew DiLoreto, Senior Director of State
Government Affairs, National Community Pharmacists Association
ACPE # 0130-0000-15-032-L04-P&T |Activity Type: Knowledge | Disclosure: Carl: President and Founder of In
Their Face Marketing and Matt: None
Friday, May 29, 2:00pm - 3:30pm | 1.5 hr | Room: Casco
Target Audience: Community Ambulatory, Independents, Long Term Care, Technicians, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Describe how to use social media as a tool to distribute health and industry information
 Discuss the fundamental elements of a website to ensure ease of use and transfer of information for patients
 Identify new and updated practices and techniques with online marketing platforms
 Review state and federal legislative/regulatory issues pertaining to independent pharmacy
A Hospital Leadership Pearls Discussion
Faculty: Megan McIntyre, Pharm.D., Medication Use Quality Manager, Pharmacy Residency, Virginia Mason
Medical Center
ACPE # 0130-0000-15-033-L04-P&T | Activity Type: Knowledge | Disclosure: None
Friday, May 29, 2:00pm - 3:30pm | 1.5 hr | Room: Kidd/North Cape
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Translate leadership pearls to your health system practice
 Describe leadership techniques highlighted in the reviewed readings
 Develop a strategy for improving your leadership skills
In this activity, Dr. McIntyre will review essential leadership pearls from a variety of hospital leadership readings
including Why Hospitals Should Fly, Straight A Leadership, and Good to Great among other great leadership reads.
Come be inspired to lead your institution and staff to greater highlights!
Supporting Student Pharmacist Success by Creating a Growth Mindset Environment
Faculty: Shannon Panther, Pharm.D., BCACP, Clinical Assistant Professor, Washington State University, College
of Pharmacy, Jennifer Robinson Pharm.D., Clinic Assistant Professor, Washington State University College of
Pharmacy, and Jeremy Hughes, Pharm.D., Director of Experiential Education and Assistant Professor, Pacific
University School of Pharmacy
ACPE # 0130-0000-15-034-L04-P&T | Activity Type: Application | Disclosure: None
Friday, May 29, 2:00pm - 3:30pm | 1.5 hr | Room: Bay 1
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Compare and contrast the impact of a growth mindset and fixed mindset on professional development
 Discuss how to create an environment that supports a growth mindset approach
 Work through case studies of difficulties commonly encountered by preceptors on rotation and identify
approaches to support positive outcomes
Encouraging students in pharmacy with praise and feedback that encourages their effort and process is critical to
developing lifelong learners. This session highlights how to incorporate a growth oriented mindset into your
teaching and precepting.
Long Term Care Forum
Moderator: Steve Boulanger, R.Ph., FASCP, Consultant Pharmacist, Mercury Pharmacy Services
ACPE # 0130-0000-15-035-L04-P&T | Activity Type: Knowledge | Conflict of Interest:
Friday, May 29, 3:40pm - 5:10pm | 1.5 hr | Room: Casco
Target Audience: Long Term Care Pharmacist, Technicians, Students
At the completion of this program, the Pharmacist and Technician will be able to:
Discuss current hot topic issues in pharmacy long term care practice
Describe strategies that other LTC professionals have employed to address the needs of their patients
This CE program is designed to target the needs of pharmacists, technicians and interns working in Long Term
Care pharmacy settings. We will discuss the current issues affecting pharmacy practice in general throughout the
Pacific Northwest as well as how these issues relate to this practice setting. Participants will be encouraged to
contribute their thoughts in this active program.
Health Systems Forum
Moderator: Megan McIntyre, Pharm.D., Medication Use Quality Manager, Pharmacy Residency, Virginia Mason
Medical Center
ACPE # 0130-0000-15-036-L04-P&T | Activity Type: Knowledge | Disclosure: None
Friday, May 29, 3:40pm - 5:10pm | 1.5 hr | Room: Kidd/North Cape
Target Audience: Health Systems, Technicians, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Discuss current trends in pharmacy practice
 Propose and discuss specific issues and needs pertaining to health system practices
 Update peers on state and federal legislative/regulatory issues pertaining to pharmacy
This CE program is designed to target the needs of pharmacists, technicians and interns working in Health System
pharmacy settings. We will discuss the current issues affecting local pharmacy practice in general as well as how
these issues relate to this practice setting. Participants will be encouraged to contribute their thoughts in this active
program.
Community/Ambulatory Practice Forum
Moderator: Steve Singer, R.Ph., Pharmacist, Bellegrove Pharmacy Services
ACPE # 0130-0000-15-037-L04-P&T | Activity Type: Knowledge | Conflict of Interest: None
Friday, May 29, 3:40pm - 5:10pm | 1.5 hr | Room: Bay 1
Target Audience: Community Ambulatory Pharmacist, Technicians, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Evaluate current trends in pharmacy practice
 Propose and discuss specific issues and needs pertaining to your practice setting
 Update peers on state and federal legislative/regulatory issues pertaining to pharmacy
 Discuss strategies to reinforce a more patient-centric mission for your profession
This CE program is designed to target the needs of pharmacists, technicians and interns working in Ambulatory/
Community Practice pharmacy settings. We will discuss the current issues affecting pharmacy practice in general
throughout the Pacific Northwest as well as how these issues relate to this practice setting. Participants will be
encouraged to contribute their thoughts in this active program.
Saturday, May 30, 2015
Keynote: Reaching a Tipping Point? Pharmacist Provider Status Efforts Escalating Across the Country
Faculty: Jeff Rochon, Pharm.D., CEO, Washington State Pharmacy Association
ACPE # 0130-0000-15-038-L04-P&T | Activity Type: Knowledge | Disclosure: None
Saturday, May 30, 8:30am -10:00am | 1.5 hr | Room: Bay 4&5
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Describe state and federal efforts that are being undertaken to include pharmacists in patient care
 Relate the upcoming steps and opportunities for pharmacists to providing care to patients
 Explain practice issues and changes supporting pharmacist provision of services
 Highlight Washington State efforts on health insurance compensation coverage for pharmacist services
Nationwide, there are both state and federal efforts to better incorporate pharmacists in health care teams
and to facilitate compensation for care. Washington State had success in 2015 with bill, ESSB 5557,
requiring health insurance carriers to include pharmacists in their networks – the first of its kind in the
country. Dr. Jeffrey Rochon will highlight the integral support of Senator Linda Evans Parlette, who is
also a pharmacist. He will review multi-state and federal level developments in Pharmacist Provided
Patient Care as well as discuss the future, anticipated challenges and opportunities on the horizon. Lastly,
Dr. Rochon will explain the movement of pharmacists as care providers in Washington State as a model
for change.
Online Marketing Strategies to Boost Your Practice
Faculty: Carl Britton Jr., President, In Their Face Marketing
ACPE # 0130-0000-15-039-L04-P&T | Activity Type: Knowledge | Disclosure: President and Founder of In Their
Face Marketing Saturday, May 30, 10:10am -11:40am | 1.5 hr | Room: Bay 1
Target Audience: Community Ambulatory, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Describe which tools are most effective in an online marketing strategy
 Demonstrate how a quality marketing strategy can improve relationships with current and prospective patients
 Explain how to develop a strategy that can be easily implemented in an everyday health service practice
Do you have an online marketing strategy? Online Marketing Strategies to Boost your Practice is a program that
will have a brief overview of the most popular and effective online marketing tools. The power behind this program
is the opportunity to place each tool into its place in an effective online marketing strategy. Attendees will leave
with their own online marketing strategy.
Pharmacist Role in HIV Pre-Exposure Prophylaxis (PrEP)
Faculty: Elyse L. Tung, Pharm.D., BCACP, Pharmacist, Kelley-Ross Pharmacy and Annalisa Z. Thomas,
Pharm.D., Community Practice Resident, Kelley-Ross Pharmacy
ACPE # 0130-0000-15-040-L02-P&T | Activity Type: Application | Disclosure: None
Saturday, May 30, 10:10am -11:40am | 1.5 hr | Room: Bay 2
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Describe the data that supports the use of emtricitabine and tenofovir (Truvada®) for the prevention of HIV
 Identify high risk individuals who would qualify for HIV PrEP
 Discuss key points in the 2014 CDC Clinical Guidelines for testing and monitoring while on HIV PrEP
 Formulate sample-counseling points for safety, efficacy and adherence
In May 2014, the US Public Health Service with the CDC published clinical practice guidelines for pre-exposure
prophylaxis for the prevention of HIV infection. This program will review key components of the guidelines and
how to apply these to patient cases.
Biosimilar Insulins: Issues and Considerations for Clinical Use
Faculty: Joshua Neumiller, Pharm.D., CDE, CGP, FACP, Associate Professor, Washington State University School
of Pharmacy
ACPE #: 0130-0000-15-041-L01-P&T | Activity Type: Knowledge | Disclosure: Consulting, Speaking & Teaching:
Janssen, Sanofi, Novo Nordisk; Grant/Research Support: AstraZeneca, Johnson & Johnson, Merck, Novo Nordisk;
Advisory Committees or Review Panels: Janssen, Sanofi
This CE is joint sponsored with Horizon CME
Saturday, May 30, 10:10am-11:10am | 1.0 hr | Room: Bay 3
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Outline the differences between biopharmaceuticals, biosimilars, and generic medications
 Discuss the FDA guidance documents and abbreviated regulatory pathway available for the licensing of
“biosimilar” products and the implications for insulin products
 Describe the potential impact that changes in manufacturing and sourcing of ingredients for biosimilar products
may have on immunogenicity, safety, and efficacy
 Discuss the critical issues of naming, interchangeability, and pharmacovigilence with biosimilar products
including biopharmaceuticals with a narrow therapeutic window such as insulin
 Identify the issues and considerations for clinical use of biosimilar insulin products
This activity will focus on the differences between biopharmaceuticals, biosimilars, and generic medications.
Faculty will discuss the current FDA guidelines for the development of biosimilars, the potential impact changes in
manufacturing and sourcing of biosimilars may have on immunogenicity, safety, and efficacy, and critical issues
with naming, interchangeability, and appropriate use of biosimilars.
Technician Forum
Moderator: Tara Millar, Technician, Kelley-Ross Compounding Pharmacy; and Kyle Sullivan, Pharm.D.
Candidate, Intern, Kelley-Ross Compounding Pharmacy
ACPE # 0130-0000-15-042-L04-P&T | Activity Type: Knowledge | Disclosure: None
Saturday, May 30, 10:10am -11:40am | 1.5 hr | Room: Casco
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Discuss current trends in pharmacy practice
 Propose and discuss specific issues and needs pertaining to your practice setting
 Update peers on state and federal legislative/regulatory issues pertaining to pharmacy
 Discuss strategies to reinforce a more patient-centric mission for our profession
This CE program is designed to target the needs of technicians and students working in various pharmacy settings.
We will discuss the current issues affecting local pharmacy practice in general as well as how these issues relate to
this practice setting. Participants will be encouraged to contribute their thoughts in this active program.
Know Pain, Know Gain: Pharmacy Patient Pain Counseling Competition
Faculty: Christopher Cook, Pharm.D., Residency Program Director, Yakima Valley Memorial Hospital
ACPE # 0130-0000-15-043-L04-P&T | Activity Type: Application | Disclosure: None
Saturday, May 30, 12:50am -2:20pm | 1.5 hr | Room: Bay 1
Sponsored by an educational grant by NASPA and Purdue Pharma, L.P
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist will be able to:
 Identify common medications and treatments used in pain management
 Illustrate main counseling points and strategies for patients with pain
 Describe common barriers for providing optimal pain management
At the completion of this program, the Technician will be able to:
 Identify common medications and treatments used in pain management
 Describe common barriers for providing optimal pain management
Often, patients with pain present unique challenges to providers. It is important to review key pain management
concepts and counseling techniques in order to optimize your patient’s treatment plan. The “Know Pain, Know
Gain” Pharmacy Patient Pain Counseling Competition will increase pharmacist and technician awareness and
involvement in patient care opportunities involving pain management. Volunteer competitors will be selected from
the audience by raffle – pick up a ticket at the door if you’d like a chance to compete and win.
Round 1 will consist of rapid fire questions to establish 3 finalists.
Round 2 will entail a case in which finalists are given three minutes to prepare then counsel in a five-minute roleplay scenario. Scoring is based on the APhA-ASP Student Counseling Competition Criteria. The winner will
receive a $50 Coeur d’Alene gift card.
Improving Medication Safety: Helping Patients to Manage and Understand the Risks
Faculty: Donna Horn, R.Ph., DPh., Director Patient Safety-Community Pharmacy, Institute for Safe Medication
Practices
ACPE # 0130-0000-15-044-L05-P&T | Activity Type: Knowledge | Disclosure: None
Saturday, May 30, 12:50pm -2:20pm | 1.5 hr | Room: Bay 2
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Describe distinctions between preventable risks and preventable errors
 Explain how patient education strategies can be used to reduce risks and errors
 Discuss strategies for explaining the risks associated with a medication to patients
 Explain why health literacy is a patient safety issue
Although medications can significantly improve patient health, they are not without risk. Risks include those that
are preventable (e.g., those arising from medication errors) and those that are unpreventable (e.g., adverse events).
Patient education by pharmacists is important for patients to understand these risks and how to manage them. Even
brief communications with patients can reduce the number of adverse events, and can minimize the impact of
medication errors. When discussing medication risks with patients, it is important to recognize that patients often
obtain information about medication risks from the media and other sources that tend to feature risks of medications
without addressing the importance of balancing risk with benefit. As a result, patients are often left with a poor
understanding of risks and how to manage them. In this session, the presenter will discuss how pharmacists can
educate patients about medication risks within the context of the risks and benefits of the medication, as well as
how to manage adverse events by adapting their communication practices to the patient’s health literacy level.
Basal Insulin Therapy in the Treatment of Insulin Resistant Type 2 Diabetes: The Role of the Pharmacist in
Ensuring Their Safe and Effective Use
Faculty: Joshua Neumiller, Pharm.D., CDE, CGP, FACP, Associate Professor, Washington State University School
of Pharmacy
ACPE #: 0130-0000-15-045-L01-P&T | Activity Type: Application | Disclosure: Consulting, Speaking &
Teaching: Janssen, Sanofi, Novo Nordisk; Grant/Research Support: AstraZeneca, Johnson & Johnson, Merck,
Novo Nordisk; Advisory Committees or Review Panels: Janssen, Sanofi
This CE is joint sponsored with Horizon CME
Saturday, May 30, 12:50pm -2:20pm | 1.5 hr | Room: Bay 3
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist will be able to:
 Describe the reasons for the use of high concentration insulin formulations in the treatment of type 2 diabetes
 Discuss the clinical, pharmacokinetic and pharmacodynamic profiles for current and emerging basal insulins
 Implement strategies for safely converting between U-100 and concentrated insulin formulations using different
syringes and pen devices in patients with type 2 diabetes
 Review currently available insulin pens and syringes used for the administration of insulin
 Explain and apply strategies to overcome the barriers to insulin-mediated glucose control
At the completion of this program, the Technician will be able to:
 Discuss the clinical, pharmacokinetic and pharmacodynamic profiles for current and emerging basal insulins
 Review currently available insulin pens and syringes used for the administration of insulin
 Explain and apply strategies to overcome the barriers to insulin-mediated glucose control
This activity will focus the use of high concentration insulin formulations in the treatment of type 2 diabetes.
Faculty will discuss the clinical, pharmacokinetic and pharmacodynamic profiles for current and emerging basal
insulins as well as currently available insulin pens and syringes used for the administration of insulin. Additionally,
faculty will provide instruction regarding strategies for safely converting between U-100 and concentrated insulin
formulations using different syringes and pen devices.
Student Forum (No CE)
Saturday, May 30, 12:50pm -2:20pm | 1.5 hr | Room: Casco
Target Audience: Students
At the completion of this program, the participant will be able to:
 Evaluate current trends in pharmacy practice
 Propose and discuss specific issues and needs pertaining to your practice setting
 Update peers on state and federal legislative/regulatory issues pertaining to pharmacy
 Discuss strategies to reinforce a more patient-centric mission for your profession
This CE program is designed to target the needs of pharmacists, technicians and interns working in Ambulatory/
Community Practice pharmacy settings. We will discuss the current issues affecting pharmacy practice in general
throughout the Pacific Northwest as well as how these issues relate to this practice setting. Participants will be
encouraged to contribute their thoughts in this active program.
Current Issues in Pharmacy Practice: Montana
Faculty: Stuart Doggett, Executive Director, Montana Pharmacy Association
ACPE # 0130-0000-15-046-L04-P&T | Activity Type: Knowledge | Disclosure: None
Saturday, May 30, 2:30pm -4:30pm | 2 hr meeting- with 1 hr of CE available for the activity | Room: Bay 1
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Discuss pharmacy legislation considered at the 2015 Montana Legislative Session
 Update peers on Board of Pharmacy rule changes including the Drug Registry Program
 Update peers on state and federal policies changes impacting pharmacist
Montana pharmacists are urged to attend the Montana Member Meeting for updates on state and federal issues. The
non CE portion of the meeting will recognize those members who have given their time and talent to enhance our
state association.
Current Issues in Pharmacy Practice: Washington
Faculty: Jeff Rochon, Pharm.D., CEO, Washington State Pharmacy Association; and Angela S. Stewart, Pharm.D.,
BCPS, Clinical Associate Professor, Director, Yakima Extension Program, College of Pharmacy, Washington State
University
ACPE # 0130-0000-15-047-L04-P&T | Activity Type: Knowledge | Disclosure: None
Saturday, May 30, 2:30pm -4:30pm | 2 hr meeting- with 1 hr of CE available for the activity | Room: Bay 2
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Discuss state and federal legislative/regulatory issues pertaining to pharmacy practice in Washington
 Describe current positive and negative trends in pharmacy practice
 Describe the priorities of the Washington State Pharmacy Association
This program is designed to educate members on the current events pertaining to the Washington State practice of
pharmacy in the last year and near future. Members are encouraged to voice their opinions and hear those of others
in this interactive session. This CE offers 1 hour of CPE.
Current Issues in Pharmacy Practice: Idaho
Faculty: Pam Eaton, Executive Director, Idaho State Pharmacy Association
ACPE # 0130-0000-15-048-L04-P&T | Activity Type: Knowledge | Disclosure: None
Saturday, May 30, 2:30pm -4:30pm | 2 hr meeting- but 1 hr of CE available for the activity | Room: Bay 3
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:



Update members on current pharmacy issues in Idaho and at the national level
Update members on the Idaho State Pharmacy Association’s activities over the past year
Plan for the future, particularly the next 12 months of the Association
This program is designed to educate members on the importance of the Idaho State Association and how it impacts
every day operations as well as the profession as a whole. Members will walk away from this meeting with an
understanding of current issues facing pharmacy in Idaho and how they can become actively involved in shaping
the practice of pharmacy on a state level. This CE offers 1 hour of CPE.
Sunday, May 31, 2015
You Snooze, You Win
Faculty: Christopher Cook, Pharm.D., Residency Program Director, Yakima Valley Memorial Hospital
ACPE # 0130-0000-15-049-L01-P&T | Activity Type: Application | Disclosure: None
Sunday, May 31, 8:00am - 9:30am | 1.5 hr | Room: Bay 2
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist will be able to:
 Define the physiology and neurochemistry regarding sleep
 Explain the breakdowns/dysfunctions in natural physiologic systems that cause sleep disorders
 Develop pharmacotherapy recommendations for patients with sleep disorders
 Provide counseling to patients regarding OTC and prescription treatments for sleep related disorders
At the completion of this program, the Technician will be able to:
 Define the physiology and neurochemistry regarding sleep
 Explain the breakdowns/dysfunctions in natural physiologic systems that cause sleep disorders
Much research is being done in the field of sleep disorders. This presentation is going to talk about misconceptions
of sleep disorders, the new pharmacologic agents used in the treatment of sleep disorders and the important
counseling topics for patients taking medications for sleep disorders.
Montana Law Update
Faculty: Marcie Bough, Pharm.D., Executive Director, Montana Board of Pharmacy
ACPE# 0130-0000-15-050-L03-P&T | Activity Type: Knowledge | Disclosure: None
Sunday, May 31, 8:00am - 9:30am | 1.5 hr | Room: Bay 3
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Describe law and regulatory updates related to the Montana Board of Pharmacy and the 2015 Legislative
Session
 Discuss Montana Prescription Drug Registry (MPDR) program activities
 Discuss future rulemaking considerations related to pharmacist-in-charge rules and license types
This program will review updates to Montana pharmacy statutes and rules. It will also discuss future rulemaking
considerations related pharmacist-in-charge rules and license types.
Drugs in the Pipeline
Faculty: Terri Levien, Pharm.D., Clinical Associate Professor, Washington State University College of Pharmacy
ACPE # 0130-0000-15-051-L01-P&T | Activity Type: Knowledge | Disclosure: None
Sunday, May 31, 9:40am-11:10am | 1.5 hr | Room: Bay 2
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Identify new drugs and new classes of drugs that are currently in development
 List several disease states with active development pipelines
 Describe the potential impact, financial and clinical, of several pipeline drugs
 Summarize the FDA approval process and describe barriers that may delay drug approval
Drugs in the Pipeline will provide an overview of drugs currently in late stage development or awaiting Food and
Drug Administration approval, with a focus on disease states with a particularly active pipeline. The potential role
of these agents will be discussed, as well as potential barriers to FDA approval.
Idaho Law Update
Faculty: Mark Johnston, R.Ph., Executive Director, Idaho State Board of Pharmacy
ACPE # 0130-0000-15-052-L03-P&T | Activity Type: Knowledge | Disclosure: None
Sunday, May 31, 9:40am -11:10am | 1.5 hr | Room: Bay 3
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacist and Technician will be able to:
 Define the Idaho State statute and rules changes enacted by the 2014 and 2015 legislature

Describe potential 2016 Idaho statute and rule changes and other current regulatory issues in pharmacy within
the state of Idaho
The Idaho Pharmacy Law update will satisfy Idaho State Board of Pharmacy rule # 052.02, which requires annually
one clock hour (0.1 CEU) of Board of Pharmacy approved jurisprudence programs. Attendees will gain an
understanding of current regulatory issues including recent statute and rules changes.
Vaccines for Adolescents: An Immunization Update
Faculty: Jenny Arnold, Pharm.D., BCPS, Director of Pharmacy Practice Development, WSPA
ACPE#: 0130-0000-15-053-L01-P&T | Activity Type: Knowledge | Disclosure: None
Sunday, May 31, 11:20am -12:50pm | 1.5 hr | Room: Bay 2
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacists will be able to:
 Identify vaccinations recommended by the Advisory Committee on Immunization Practices for adolescents
 Make a strong recommendation for vaccines to parents of adolescents
 Discuss strategies for recommending the HPV vaccine to patients
 Review barriers to adolescent vaccinations
At the completion of this program, the Technicians will be able to:
 Identify vaccinations recommended by the Advisory Committee on Immunization Practices for adolescents
 Discuss the diseases adolescent vaccinations prevent
 Identify optimal times for adolescent vaccinations
 List strategies to discuss the HPV vaccine with patients
Adolescents need an increasing number of immunizations to prevent illness, and to enter school. Pharmacists are
uniquely poised to offer vaccinations to adolescent patients, especially HPV vaccine, a three dose vaccine series.
There is a perceived hesitancy by parents to vaccinate their adolescents with all recommended vaccines. This CE
discusses the recommended vaccines for adolescent patients, as well as strategies for recommending these vaccines.
Washington Law Update
Faculty: Chris Humberson, R.Ph., Executive Director, Pharmacy Quality Assurance Commission, Dept. of Health
ACPE#: 0130-0000-15-054-L03-P&T | Activity Type: Knowledge | Disclosure: None
Sunday, May 31, 11:20am -12:50pm | 1.5 hr | Room: Bay 3
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Independent, Technician, Students
At the completion of this program, the Pharmacists and Technicians will be able to:
 Describe how to apply new laws and rules to pharmacy practice
 State how to put patient safety and pharmacy care first while adhering to pharmacy law
 Identify the Commission’s agenda for new and updated areas of practice regulation
 Recall the pharmacy practitioners’ responsibilities for new and updated regulations
This program will discuss application of new laws and regulations. Topics will include new state requirements for
licensure, handling of hazardous drugs, practices requiring commission approval, adverse event reporting,
Collaborative Drug Therapy Agreements, Pharmacy Compounding and tamper evident prescription paper and pads
and more.
Meeting Information
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy
Education as a Provider of continuing pharmacy education
CE Information & Requirements:
In order to receive credit, you need to do three things:
1. Complete and turn in the Statement of Attendance at the end of the conference. For each activity attended,
please write the activity code next to its title to verify your participation. The code will be provided at the end
of each session. The yellow copy is for your records.
2. Make sure that WSPA has your NABP e-profile ID and birth date (MMDD). This is required to process CE.
The CPE will be uploaded to the CPE monitor within 60 days of the conference. You will receive a
confirmation email once it is completed.
3. Submit an evaluation. We will have a hard copy in your packet to record your thoughts and ask you to submit
the information on-line. To submit the form on-line, go to www.wsparx.org and on the front-page click on
“Northwest Pharmacy Convention”, which will take you to the convention page where you can access the online evaluation and presentations.
All continuing education credits are uploaded to the CPE Monitor by the provider (WSPA) within 45 days of
the conference. An email will be sent to notify you that the CE has been uploaded.
Color Coded Cards:
To facilitate the questions and answers, WSPA has provide you with a set of 4 colored cards (orange, yellow, pink
and green) to answer questions within the CE activity. Please keep those in your name badge, and use them to
interact with the speakers during each activity.